Raichur (Karnataka) [India], August 28: In a major breakthrough, Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED) proudly announces the successful completion of its Phase 1 clinical trial for its flagship product, sRbumin® - recombinant human albumin® 20% (rHA), becoming the
Washington [US], January 31 (ANI): A team of researchers has developed an approach that accelerates the detection of cancer biomarkers in samples taken at the time and place of patient care.
New Delhi [India] June 5 (ANI): Indigenous IgG-based ELISA kits for COVID-19 testing have been found to be sensitive and specific for the detection of coronavirus infection in human serum samples.